The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Amyotrophic Lateral Sclerosis Treatment Market Research Report 2024

Global Amyotrophic Lateral Sclerosis Treatment Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1713818

No of Pages : 94

Ask Your Query

Synopsis

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.

The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.

According to QYResearch’s new survey, global Amyotrophic Lateral Sclerosis Treatment market is projected to reach US$ 380.6 million in 2029, increasing from US$ 300 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Amyotrophic Lateral Sclerosis Treatment market research.

GlobalAmyotrophic Lateral Sclerosis (ALS) Treatment key players include Mitsubishi Tanabe Pharma, Sanofi, etc. Global top two manufacturers hold a share over 80%.

North America is the largest market, with a share about 60%, followed by Japan, and Europe, both have a share over 20 percent. 
In terms of product, Edaravone (Radicava) is the largest segment, with a share over 75%. And in terms of application, the largest application is Hospital, followed by Drugs Store, etc.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Amyotrophic Lateral Sclerosis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Sanofi
  •     Roche
  •     Biogen
  •     Mitsubishi Tanabe Pharma
  •     GNT Pharma
  •     Synthetic Biologics
  •     Amkor Pharma
  •     ViroMed
  •     Brainstorm Therapeutics
  •     Bausch Health

Segment by Type

  •     Medication
  •     Physical Therapy
  •     Speech Therapy
  •     Others

Segment by Application

  •     Hospitals
  •     Specialty Centers
  •     Research Centers
  •     Others

By Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Amyotrophic Lateral Sclerosis Treatment report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

 

  1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Amyotrophic Lateral Sclerosis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Medication
        1.2.3 Physical Therapy
        1.2.4 Speech Therapy
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Amyotrophic Lateral Sclerosis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospitals
        1.3.3 Specialty Centers
        1.3.4 Research Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Amyotrophic Lateral Sclerosis Treatment Market Perspective (2018-2029)
    2.2 Amyotrophic Lateral Sclerosis Treatment Growth Trends by Region
        2.2.1 Global Amyotrophic Lateral Sclerosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Amyotrophic Lateral Sclerosis Treatment Historic Market Size by Region (2018-2023)
        2.2.3 Amyotrophic Lateral Sclerosis Treatment Forecasted Market Size by Region (2024-2029)
    2.3 Amyotrophic Lateral Sclerosis Treatment Market Dynamics
        2.3.1 Amyotrophic Lateral Sclerosis Treatment Industry Trends
        2.3.2 Amyotrophic Lateral Sclerosis Treatment Market Drivers
        2.3.3 Amyotrophic Lateral Sclerosis Treatment Market Challenges
        2.3.4 Amyotrophic Lateral Sclerosis Treatment Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Amyotrophic Lateral Sclerosis Treatment Players by Revenue
        3.1.1 Global Top Amyotrophic Lateral Sclerosis Treatment Players by Revenue (2018-2023)
        3.1.2 Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Players (2018-2023)
    3.2 Global Amyotrophic Lateral Sclerosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis Treatment Revenue
    3.4 Global Amyotrophic Lateral Sclerosis Treatment Market Concentration Ratio
        3.4.1 Global Amyotrophic Lateral Sclerosis Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Treatment Revenue in 2022
    3.5 Amyotrophic Lateral Sclerosis Treatment Key Players Head office and Area Served
    3.6 Key Players Amyotrophic Lateral Sclerosis Treatment Product Solution and Service
    3.7 Date of Enter into Amyotrophic Lateral Sclerosis Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Amyotrophic Lateral Sclerosis Treatment Breakdown Data by Type
    4.1 Global Amyotrophic Lateral Sclerosis Treatment Historic Market Size by Type (2018-2023)
    4.2 Global Amyotrophic Lateral Sclerosis Treatment Forecasted Market Size by Type (2024-2029)

 5 Amyotrophic Lateral Sclerosis Treatment Breakdown Data by Application
    5.1 Global Amyotrophic Lateral Sclerosis Treatment Historic Market Size by Application (2018-2023)
    5.2 Global Amyotrophic Lateral Sclerosis Treatment Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America Amyotrophic Lateral Sclerosis Treatment Market Size (2018-2029)
    6.2 North America Amyotrophic Lateral Sclerosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2018-2023)
    6.4 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Amyotrophic Lateral Sclerosis Treatment Market Size (2018-2029)
    7.2 Europe Amyotrophic Lateral Sclerosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2018-2023)
    7.4 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size (2018-2029)
    8.2 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Region (2018-2023)
    8.4 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size (2018-2029)
    9.2 Latin America Amyotrophic Lateral Sclerosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2018-2023)
    9.4 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size (2018-2029)
    10.2 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2018-2023)
    10.4 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Detail
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Amyotrophic Lateral Sclerosis Treatment Introduction
        11.1.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2018-2023)
        11.1.5 Sanofi Recent Development
    11.2 Roche
        11.2.1 Roche Company Detail
        11.2.2 Roche Business Overview
        11.2.3 Roche Amyotrophic Lateral Sclerosis Treatment Introduction
        11.2.4 Roche Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2018-2023)
        11.2.5 Roche Recent Development
    11.3 Biogen
        11.3.1 Biogen Company Detail
        11.3.2 Biogen Business Overview
        11.3.3 Biogen Amyotrophic Lateral Sclerosis Treatment Introduction
        11.3.4 Biogen Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2018-2023)
        11.3.5 Biogen Recent Development
    11.4 Mitsubishi Tanabe Pharma
        11.4.1 Mitsubishi Tanabe Pharma Company Detail
        11.4.2 Mitsubishi Tanabe Pharma Business Overview
        11.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Introduction
        11.4.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2018-2023)
        11.4.5 Mitsubishi Tanabe Pharma Recent Development
    11.5 GNT Pharma
        11.5.1 GNT Pharma Company Detail
        11.5.2 GNT Pharma Business Overview
        11.5.3 GNT Pharma Amyotrophic Lateral Sclerosis Treatment Introduction
        11.5.4 GNT Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2018-2023)
        11.5.5 GNT Pharma Recent Development
    11.6 Synthetic Biologics
        11.6.1 Synthetic Biologics Company Detail
        11.6.2 Synthetic Biologics Business Overview
        11.6.3 Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Introduction
        11.6.4 Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2018-2023)
        11.6.5 Synthetic Biologics Recent Development
    11.7 Amkor Pharma
        11.7.1 Amkor Pharma Company Detail
        11.7.2 Amkor Pharma Business Overview
        11.7.3 Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Introduction
        11.7.4 Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2018-2023)
        11.7.5 Amkor Pharma Recent Development
    11.8 ViroMed
        11.8.1 ViroMed Company Detail
        11.8.2 ViroMed Business Overview
        11.8.3 ViroMed Amyotrophic Lateral Sclerosis Treatment Introduction
        11.8.4 ViroMed Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2018-2023)
        11.8.5 ViroMed Recent Development
    11.9 Brainstorm Therapeutics
        11.9.1 Brainstorm Therapeutics Company Detail
        11.9.2 Brainstorm Therapeutics Business Overview
        11.9.3 Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Introduction
        11.9.4 Brainstorm Therapeutics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2018-2023)
        11.9.5 Brainstorm Therapeutics Recent Development
    11.10 Bausch Health
        11.10.1 Bausch Health Company Detail
        11.10.2 Bausch Health Business Overview
        11.10.3 Bausch Health Amyotrophic Lateral Sclerosis Treatment Introduction
        11.10.4 Bausch Health Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2018-2023)
        11.10.5 Bausch Health Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock